Patients taking direct oral anticoagulants (DOACs) are often considered to be at increased risk for bleeding after therapeutic endoscopic procedures such as polypectomy and sphincterotomy.
direct oral anticoagulants
direct oral anticoagulants
Endoscopic Biopsy in Patients Exposed to Direct Oral Anticoagulants Is Claimed To Be Safe
Endoscopic Biopsy in Patients Exposed to Direct Oral Anticoagulants Is Claimed To Be Safe
Prophylactic Clipping to Prevent Postpolypectomy Bleeding After Oral Anticoagulants
Prophylactic Clipping to Prevent Postpolypectomy Bleeding After Oral Anticoagulants
Prophylactic clipping is generally considered effective for endoscopic mucosal resection (EMR) defects of lesions ≥20 mm removed with electrocautery and proximal to the splenic flexure.
Stopping Direct Oral Anticoagulants on the Day of Colonoscopy Was Enough to Prevent Bleeding After Cold Snare Polypectomy
Stopping Direct Oral Anticoagulants on the Day of Colonoscopy Was Enough to Prevent Bleeding After Cold Snare Polypectomy
Direct oral anticoagulants (DOACs) are often stopped a couple of days before colonoscopy and resumed one or more days after the procedure, depending on thromboembolism
Want To Take Out Polyps in Anticoagulated Patients? New Data Indicate Apixaban Is the Drug To Be On
Want To Take Out Polyps in Anticoagulated Patients? New Data Indicate Apixaban Is the Drug To Be On
This retrospective cohort study evaluated postpolypectomy bleeding and thromboembolism risks with warfarin, apixaban, dabigatran, and rivaroxaban use in Hong Kong public hospitals between January 2012
Poor Compliance With Antithrombotic Guidelines Associated With Bad Outcomes
Poor Compliance With Antithrombotic Guidelines Associated With Bad Outcomes
Rates of polypectomy in colonoscopy are high for all indications; therefore, clinicians usually stop antiplatelet and antithrombotic agents other than aspirin prior to colonoscopy and
